# The Rosuvastatin In TrAnsplant Recipients Study

> **NCT01524601** · PHASE4 · COMPLETED · sponsor: **University of Oslo School of Pharmacy** · enrollment: 20 (actual)

## Conditions studied

- Disorder Related to Renal Transplantation
- Hypercholesterolemia

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT01524601
- **Lead sponsor:** University of Oslo School of Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01524601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01524601, "The Rosuvastatin In TrAnsplant Recipients Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01524601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*